Clinical trial · Interventional
Clinical Trial Comparing Outcomes of Breast Conserving Operations With Classic v High-frequency Electrocoagulation
Prospective, Randomized Clinical Trial Comparing Pain Sensation, Seroma Formation and Quality od Life Following BCT With SLND in Breast Cancer Patients Operated With Classic Versus High-frequency Electrocoagulation.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to assess the outcomes of breast conserving therapy operation depending on the type of surgical tool used: classic electrocoagulation with higher operative temperatures and high frequency electrocoagulation with lower operative temperatures. The investigators would assess the pain levels, length and amount of the lymphatic secretion as well as quality of life following breast conserving surgery.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| classic v high-frequency electrocoagulation | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Classic electrocoagulation
- description
- Arm of the study where the classic low-frequency electrocoagulation is used during the operation
- interventionNames
- Device: classic v high-frequency electrocoagulation
- type
- EXPERIMENTAL
- label
- High Frequency electrocoagulation
- description
- Arm of the study where the tested high-frequency electrocoagulation is used during the operation
- interventionNames
- Device: classic v high-frequency electrocoagulation
Primary outcomes (1)
- measure
- Pain Control
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * female * age 18-100 * breast cancer * stage IIA and II B (cT1a-3; cN0-1; cM0) * no previous breast surgery * no previous cancer * obtained informed consent Exclusion Criteria: * stages I, III, IV * localised breast infection * previous breast surgery for any cause * previous cancer * no voluntary consent
References
Publications (0)
Data not yet available